SK286961B6 - Spôsob výroby 2-aminobenzofenónu - Google Patents
Spôsob výroby 2-aminobenzofenónu Download PDFInfo
- Publication number
- SK286961B6 SK286961B6 SK63-2001A SK632001A SK286961B6 SK 286961 B6 SK286961 B6 SK 286961B6 SK 632001 A SK632001 A SK 632001A SK 286961 B6 SK286961 B6 SK 286961B6
- Authority
- SK
- Slovakia
- Prior art keywords
- reaction
- represented
- acid
- aminobenzophenone
- aluminum chloride
- Prior art date
Links
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title description 7
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims abstract description 22
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 125000004421 aryl sulphonamide group Chemical group 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 20
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 6
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000005881 detosylation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- 238000007070 tosylation reaction Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- FFFXIQFESQNINT-UHFFFAOYSA-N (2-aminophenyl)-(4-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1 FFFXIQFESQNINT-UHFFFAOYSA-N 0.000 description 1
- FUADXEJBHCKVBN-UHFFFAOYSA-N (3-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 FUADXEJBHCKVBN-UHFFFAOYSA-N 0.000 description 1
- ADALGBTXGIISDM-UHFFFAOYSA-N 2-[(4-methylphenyl)sulfonylamino]benzoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC=C1C(O)=O ADALGBTXGIISDM-UHFFFAOYSA-N 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- YKGMKSIHIVVYKY-UHFFFAOYSA-N dabrafenib mesylate Chemical compound CS(O)(=O)=O.S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 YKGMKSIHIVVYKY-UHFFFAOYSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000013146 percutaneous coronary intervention Methods 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20791098 | 1998-07-23 | ||
PCT/JP1999/003922 WO2000005195A1 (fr) | 1998-07-23 | 1999-07-22 | Procede de production d'un compose 2-aminobenzophenone |
Publications (2)
Publication Number | Publication Date |
---|---|
SK632001A3 SK632001A3 (en) | 2001-08-06 |
SK286961B6 true SK286961B6 (sk) | 2009-08-06 |
Family
ID=16547602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK63-2001A SK286961B6 (sk) | 1998-07-23 | 1999-07-22 | Spôsob výroby 2-aminobenzofenónu |
Country Status (21)
Country | Link |
---|---|
US (1) | US6310249B1 (cs) |
EP (1) | EP1099687B1 (cs) |
JP (1) | JP4232337B2 (cs) |
KR (1) | KR100594339B1 (cs) |
CN (1) | CN1131204C (cs) |
AT (1) | ATE259347T1 (cs) |
AU (1) | AU746711B2 (cs) |
CA (1) | CA2338421C (cs) |
CZ (1) | CZ300228B6 (cs) |
DE (1) | DE69914763T2 (cs) |
DK (1) | DK1099687T3 (cs) |
ES (1) | ES2216533T3 (cs) |
IL (1) | IL140925A0 (cs) |
NO (1) | NO317811B1 (cs) |
NZ (1) | NZ509399A (cs) |
PT (1) | PT1099687E (cs) |
RU (1) | RU2223945C2 (cs) |
SK (1) | SK286961B6 (cs) |
UA (1) | UA58601C2 (cs) |
WO (1) | WO2000005195A1 (cs) |
ZA (1) | ZA200100526B (cs) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270060B (zh) * | 2008-05-07 | 2011-02-02 | 重庆医科大学 | 2,6-二(氨基苯亚甲基)环烷酮类化合物及其制备方法和用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB332208A (en) * | 1929-01-15 | 1930-07-15 | Ig Farbenindustrie Ag | Process for the manufacture of azo dyestuffs |
US3297755A (en) * | 1960-12-02 | 1967-01-10 | Hoffmann La Roche | 2-chloro-5-trifluoromethylbenzo-phenone compounds |
BE622079A (cs) * | 1961-09-11 | |||
DE69303996T2 (de) * | 1992-07-06 | 1997-02-27 | American Cyanamid Co | o-Nitrophenyl Cyclopropyl Keton, herbizides Zwischenprodukt und Verfahren zu seiner Herstellung |
CZ289916B6 (cs) * | 1993-11-30 | 2002-04-17 | American Cyanamid Company | Způsob výroby o-aminofenylketonů |
-
1999
- 1999-07-22 DK DK99931483T patent/DK1099687T3/da active
- 1999-07-22 CN CN99808967A patent/CN1131204C/zh not_active Expired - Fee Related
- 1999-07-22 DE DE69914763T patent/DE69914763T2/de not_active Expired - Lifetime
- 1999-07-22 WO PCT/JP1999/003922 patent/WO2000005195A1/ja active IP Right Grant
- 1999-07-22 PT PT99931483T patent/PT1099687E/pt unknown
- 1999-07-22 EP EP99931483A patent/EP1099687B1/en not_active Expired - Lifetime
- 1999-07-22 ES ES99931483T patent/ES2216533T3/es not_active Expired - Lifetime
- 1999-07-22 US US09/743,810 patent/US6310249B1/en not_active Expired - Lifetime
- 1999-07-22 KR KR1020017000688A patent/KR100594339B1/ko not_active Expired - Fee Related
- 1999-07-22 RU RU2001105198/04A patent/RU2223945C2/ru not_active IP Right Cessation
- 1999-07-22 CZ CZ20010063A patent/CZ300228B6/cs not_active IP Right Cessation
- 1999-07-22 SK SK63-2001A patent/SK286961B6/sk not_active IP Right Cessation
- 1999-07-22 JP JP2000561152A patent/JP4232337B2/ja not_active Expired - Fee Related
- 1999-07-22 NZ NZ509399A patent/NZ509399A/en not_active IP Right Cessation
- 1999-07-22 IL IL14092599A patent/IL140925A0/xx not_active IP Right Cessation
- 1999-07-22 AT AT99931483T patent/ATE259347T1/de active
- 1999-07-22 AU AU47991/99A patent/AU746711B2/en not_active Ceased
- 1999-07-22 UA UA2001010586A patent/UA58601C2/uk unknown
- 1999-07-22 CA CA002338421A patent/CA2338421C/en not_active Expired - Fee Related
-
2001
- 2001-01-18 ZA ZA200100526A patent/ZA200100526B/en unknown
- 2001-01-22 NO NO20010356A patent/NO317811B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4232337B2 (ja) | 2009-03-04 |
ATE259347T1 (de) | 2004-02-15 |
CN1131204C (zh) | 2003-12-17 |
NO20010356L (no) | 2001-01-22 |
CN1310703A (zh) | 2001-08-29 |
RU2223945C2 (ru) | 2004-02-20 |
NO20010356D0 (no) | 2001-01-22 |
WO2000005195A1 (fr) | 2000-02-03 |
SK632001A3 (en) | 2001-08-06 |
KR100594339B1 (ko) | 2006-06-30 |
CZ300228B6 (cs) | 2009-03-25 |
ES2216533T3 (es) | 2004-10-16 |
EP1099687A4 (en) | 2003-01-02 |
IL140925A0 (en) | 2002-02-10 |
UA58601C2 (uk) | 2003-08-15 |
NZ509399A (en) | 2002-03-01 |
AU746711B2 (en) | 2002-05-02 |
EP1099687B1 (en) | 2004-02-11 |
EP1099687A1 (en) | 2001-05-16 |
DE69914763D1 (de) | 2004-03-18 |
PT1099687E (pt) | 2004-06-30 |
CA2338421C (en) | 2007-05-08 |
KR20010071938A (ko) | 2001-07-31 |
ZA200100526B (en) | 2001-08-02 |
NO317811B1 (no) | 2004-12-13 |
US6310249B1 (en) | 2001-10-30 |
AU4799199A (en) | 2000-02-14 |
DE69914763T2 (de) | 2004-07-15 |
DK1099687T3 (da) | 2004-04-13 |
CA2338421A1 (en) | 2000-02-03 |
CZ200163A3 (en) | 2001-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4571863B2 (ja) | 抗痛覚過敏剤として有用なキナゾリノン誘導体 | |
JPH0653736B2 (ja) | 新規な酸性インド−ル化合物 | |
HU219241B (en) | Amide derivatives, their preparation, intermediates and pharmaceutical compns. contg. the said amide derivatives | |
DK149230B (da) | Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf | |
SK286961B6 (sk) | Spôsob výroby 2-aminobenzofenónu | |
NZ229636A (en) | A process for the preparation of 2,6-dichlorodiphenylamino-acetic acid derivatives | |
JPS58134091A (ja) | 2−アシル−1,3,4,6,7,11b−ヘキサヒドロ−2H−ピラジノ−〔2,1−a〕−4−イソキノリノン及び中間体の製造方法 | |
RU2315044C2 (ru) | Способ получения хиральных 1,4-дизамещенных пиперазинов | |
Jiang et al. | An expedient route for the practical preparation of optically active (−)-gossypol | |
JP5606440B2 (ja) | チアベンゾアズレンプロピオン酸誘導体の製造法 | |
JP2894804B2 (ja) | 2―アミノ―5―メチルベンゾフェノン類及びその製造法 | |
US9611217B2 (en) | Synthetic processes of carprofen | |
CN107400088A (zh) | 1,3‑二取代吡唑类衍生物及其制备方法与应用 | |
DK156391B (da) | Analogifremgangsmaade til fremstilling af 3-aminopyrrolderivater | |
JP3347745B2 (ja) | ケトプロフェンの製造法 | |
TW200836742A (en) | Benzoquinazoline derivatives | |
CN118165004A (zh) | 一种Type-II型GSK-3β抑制剂及其制备方法与应用 | |
JPS61112051A (ja) | 3−アミノ−2−ベンゾイルアクリル酸誘導体およびその合成方法 | |
JPS5832866A (ja) | 光学活性2−オキソイミダゾリジン−4−カルボン酸誘導体の製法 | |
TW200400165A (en) | Process for preparing trans-4-aminocylcohexanecarboxylic acids | |
JPS61148149A (ja) | 2−アシルアミノ−5−アルキル−4,6−ジハロゲノフエノ−ルの製法 | |
JPH06287176A (ja) | 2−アミノ−3−ニトロピリジン類の製造方法 | |
JP2004331554A (ja) | フタラジンの製造方法 | |
JPH02300154A (ja) | 安息香酸誘導体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20150722 |